Table 1.
Baseline characteristics of 536 patients that underwent 1,472 EBL procedures.
| Age (years) | 61 (52–70) |
| Sex (M/F) | 384/152 |
| Child score | 6 (5–8) |
| Child class A, B, C (%) | 59/33/8 |
| MELD | 11 (8–14) |
| Etiology: HCV, alcohol, other (%) | (40,31,29) |
| Primary prophylaxis/Secondary prophylaxis (%) | 51/49 |
| Creatinine (mg/dl) | 0.8 (0.7–1.1) |
| Bilirubin (mg/dl) | 1.3 (0.8–2.0) |
| INR | 1.26 (1.15–1.42) |
| Platelets x 109/L | 91 (60–126) |
| APTT (seconds) | 31 (28–34) |
| Fibrinogen (g/L) | 2.6 (2–3.6) |
| Transfusion pre-procedure n (%) | |
| Any blood product | 37 (6.9) |
| FFP | 18 (3.4) |
| Platelets | 24 (4.5) |
| Bleeding n (%) | 26 (4.8) |
| Early (within 24 hours) | 5 (0.9) |
| Late (within 15 days) | 21 (3.9) |
APTT, activated partial thromboplastin time; EBL, endoscopic band ligation; FFP, fresh frozen plasma; INR, international normalized ratio; MELD, model for end-stage liver disease.